STTK Shattuck Labs Inc Net earnings per share growth forecast for next year
Is it worth investing in Shattuck Labs, Inc. (STTK), given the risks of logistics disruptions and the freezing of scientific progress due to national isolation? The forward earnings per share trend displayed on GURU.Markets provides the answer: the metric has leveled off at -5.30. The business relies on the non-cyclical nature of R&D, which remains independent of GDP, while the stability of operations in the US protects developments from trade conflicts.
Shattuck Labs Inc - analytical breakdowns and key metrics (STTK)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Total Debt to Capital Shattuck Labs, Inc.|STTK - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Shattuck Therapeutics|STTK - Company Aggregate Debts|Debt to Book Value Shattuck Labs|STTK - Amount of Long-Term Liabilities|Company Current Liabilities Shattuck Labs|Quick Liquidity Indicator shattucklabs.com
- earnings and valuation multiples information:
STTK - Net Profit|Projected Future Earnings Shattuck Labs, Inc.|STTK - Price to Earnings Ratio|Future Price to Earnings Shattuck Therapeutics|STTK - PEG Multiple|Enterprise Value to EBITDA Ratio Shattuck Therapeutics|STTK - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Shattuck Labs|STTK - Earnings per share for the last twelve months|Quarterly EPS earnings growth shattucklabs.com|STTK - Earnings growth in current year|Earnings growth forecast for next year Shattuck Labs, Inc.
- total revenue and sales volume data:
Basic company analysis:Shattuck Labs, Inc.
Shattuck Labs, Inc. (STTK) investments in a premier staff of oncologists and large-scale R&D programs directly determine the future monetization of its scientific discoveries. This metric measures the expected percentage growth in earnings per share by aggregating analyst consensus forecasts for future cash flows. The trend in projected one-year forward net income per share allows for an assessment of the business model's resilience to stress scenarios and the risks of asset overvaluation.
Direct competitors
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year biontech.de|Net earnings per share growth forecast for next year Abivax Corp (ABVX)|ADMA Biologics, Inc. - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (protagonist-inc.com)|Immunovant Corp (IMVT) - Expected net earnings per share growth next year|KNSA - Net earnings per share growth forecast for next year|Net earnings per one share growth forecast for next year grifols.com (GRFS)|ADPT: Earnings growth forecast for next year|Expected net earnings per share growth next year Celldex Therapeutics Inc (CLDX)|Net earnings per share growth forecast for next year Aurinia Pharma|Expected net earnings per share growth next year BioCryst Pharmaceuticals Inc BCRX|Earnings growth forecast for next year VERA|Dianthus Therapeutics, Inc. - Projected earnings per share growth rate for next year|Pharvaris - Expected earnings per share growth for next year|AbCellera Biologics Inc. - Net earnings per share growth forecast for next year|Tourmaline Bio Inc - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Intrexon (PGEN)|Pharming Group (PHAR) - Net earnings per share growth forecast for next year|Nektar Therapeutics Inc. - Expected earnings per share trend next year|Expected earnings per share growth for next year UPB|Zenas Bio (ZBIO) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year IMNM (Immunome Corp)|GOSS (Gossamer Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year KalVista Pharmaceuticals Inc KALV|Consensus forecast of earnings per share growth for next year septerna.com (SEPN)|PVLA - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Savara Inc SVRA|RIGL: Earnings growth forecast for next year|ANAB - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Astria Pharma|Projected earnings per share growth rate for next year ENGN (enGene Holdings Inc.)|Expected earnings per share growth for next year RAPT (RAPT Therapeutics, Inc.)|Earnings growth forecast for next year Aerovate Therapeutics, Inc. (JBIO)|Earnings growth forecast for next year ACRS (aclaristx.com)|Kyverna Therapeutics (KYTX) - Expected net earnings per share growth next year|tizianalifesciences.com - Earnings growth forecast for next year|CABA (Cabaletta Bio, Inc.) - Projected earnings per share growth rate for next year|VTYX: Earnings growth forecast for next year|THTX - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Avalo Therapeutics Inc|Eledon (ELDN) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year agenusbio.com (AGEN)|CLYM (Climb Bio Inc) - Expected earnings per share trend next year|Earnings growth forecast for next year ZURA (zurabio.com)|Expected earnings per share trend next year ATYR|ADAG - Net earnings per share growth forecast for next year|ikenaoncology.com (IMA) - Expected earnings per share growth for next year|EQ: Earnings growth forecast for next year|Net earnings per share change forecast for next year CNTB (Connect Biopharma Holdings)|Expected earnings per share growth for next year IMUX|ATRA (atarabio.com) - Projected earnings per share increase next year|Earnings growth forecast for next year IFRX|Earnings growth forecast for next year X4 Pharma (XFOR)|Adicet Bio Inc. - Expected earnings per share growth for next year|Earnings growth forecast for next year celularity.com CELU|INMB: Expected earnings per share growth for next year|BRNS: Net earnings per share growth forecast for next year|KZR: Earnings growth forecast for next year|SAB Biotherapeutics Inc - Expected earnings per share trend next year|AKTX (Akari Therapeutics, Plc) - Earnings growth forecast for next year|ENLV: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Q32 Bio (QTTB)|Expected earnings per share growth for next year GeoVax Labs GOVX|Earnings growth forecast for next year EDSA (Edesa Biotech Corp)|iBio, Inc. (IBIO) - Expected net earnings per share growth next year|CARM: Expected earnings per share growth for next year|XTL Biopharmaceuticals (XTLB) - Expected earnings per share growth for next year|BOLT: Earnings growth forecast for next year|Expected earnings per share growth for next year HCW Biologics Inc.|Net earnings per share growth forecast for next year aptevotherapeutics.com|AIM: Expected earnings per share trend next year|Net earnings per share growth forecast for next year aditxt.com (ADTX)|GRI - Expected net earnings per share growth next year|Earnings growth forecast for next year XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences (HIND) - Expected net earnings per share growth next year|REVB - Net earnings per share growth forecast for next year|INDP - Earnings growth forecast for next year|SCNI: Earnings growth forecast for next year|Expected earnings per share growth for next year CalciMedica Inc|AFMD (Affimed Therapeutics) - Earnings growth forecast for next year|allakos.com (ALLK) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year HOOKIPA Pharma Inc. (HOOK)|IGM Biosciences Inc. (IGMS) - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year iteostherapeutics.com ITOS|OCEA - Expected earnings per share growth for next year|TC BioPharm (Holdings) Plc - Earnings growth forecast for next year|Expected earnings per share trend next year THRD (Third Harmonic Bio, Inc.)
